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1Department of Neurology, Washington University School of Medicine, St. Louis, MO, United States, 2 Faculty of Health
Sciences, School of Public Health, University of the Witwatersrand, Parktown, Johannesburg, South Africa, 3 Institute for
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Background: The prevalence of parkinsonism in developing countries is largely
unknown due to difficulty in ascertainment because access to neurologists is
often limited.
Objective: Develop and validate a parkinsonism screening tool using objective motor
task-based tests that can be administered by non-clinicians.
Methods: In a cross-sectional population-based sample from South Africa, we
evaluated 315 adults, age >40, from an Mn-exposed (smelter) community, using
the Unified Parkinson Disease Rating Scale motor subsection 3 (UPDRS3), Purdue
grooved pegboard, and kinematic-UPDRS3-based motor tasks. In 275 participants
(training dataset), we constructed a linear regression model to predict UPDRS3.
We selected motor task summary measures independently associated with UPDRS3
(p < 0.05). We validated the model internally in the remaining 40 participants from
the manganese-exposed community (test dataset) using the area under the receiver
operating characteristic curve (AUC), and externally in another population-based sample
of 90 participants from another South African community with only background levels of
environmental Mn exposure.
Results: Themean UPDRS3 score in participants from theMn-exposed community was
9.1 in both the training and test datasets (standard deviation= 6.4 and 6.1, respectively).
Together, 57 (18.1%) participants in this community had a UPDRS3 ≥ 15, including three
with Parkinson’s disease. In the non-exposed community, the mean UPDRS3 was 3.9
(standard deviation = 4.3). Three (3.3%) had a UPDRS3 ≥ 15. Grooved pegboard time
and mean velocity for hand rotation and finger tapping tasks were strongly associated
with UPDRS3. Using these motor task summary measures and age, the UPDRS3
predictive model performed very well. In the test dataset, AUCs were 0.81 (95% CI 0.68,
0.94) and 0.91 (95% CI 0.81, 1.00) for cut points for neurologist-assessed UPDRS3 ≥
10 and UPDRS3 ≥ 15, respectively. In the external validation dataset, the AUC was 0.85
(95% CI 0.73, 0.97) for UPDRS3 ≥ 10. AUCs were 0.76–0.82 when excluding age.
Conclusion: A predictive model based on a series of objective motor tasks performs
very well in assessing severity of parkinsonism in both Mn-exposed and non-exposed
population-based cohorts.
Keywords: kinematics, manganese, parkinsonism, predictive model, receiver operating characteristic
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INTRODUCTION
The Global Burden of Disease Study estimates that the number of
people affected by Parkinson’s disease (PD) more than doubled
from 1990 to 2015 with the highest prevalence in high-income
regions and lowest in sub-Saharan Africa and Eastern Europe
in 2015 (1, 2). However, little is known about the burden
of the disease in resource-poor environments such as many
regions in Africa (3). Relatively low reported PD prevalence in
Africa is almost certainly inaccurate, since case identification is
challenging in countries that lack sufficient research and clinical
expertise to survey their populations (4). Globally, there are 3.1
neurologists per 100,000 people, whereas in Africa there are only
0.1 neurologists per 100,000 people (5). Given the increasing life
expectancy in many African countries, estimating true disease
burden of diseases of aging, such as PD, is critical to providing
adequate healthcare resources for these patients.
The Unified Parkinson Disease Rating Scale motor subsection
3 (UPDRS3) remains the most widely used tool to quantify
parkinsonian motor signs in patient and non-patient populations
(6–10). In addition to quantifying parkinsonism severity, this
standardized examination elicits the cardinal signs required
to make a diagnosis of PD. Nevertheless, many developing
countries lack the relevant clinical expertise required to quantify
parkinsonism or diagnose PD accurately. For this study, we
sought to develop a motor battery that can be used to predict
UPDRS3 scores in population-based African cohorts. In practice,
such estimates of the UPDRS3 score might be useful for
initial screening to identify those who should receive further
evaluation by a neurologist. These UPDRS3 estimates might also
be suitable for epidemiological studies investigating neurological
health effects of environmental or occupational exposures when




The Washington University School of Medicine Human
Research Protection Office (St. Louis, Missouri, United States)
and the University of the Witwatersrand Human Research Ethics
Committee (Johannesburg, Gauteng, South Africa) approved this
study. All participants provided written informed consent.
Participants
Within a cross-sectional population-based study with 315 South
African adults age>40 and living<5 km from a large manganese
(Mn) smelter in Meyerton, South Africa, we developed and
validated a predictive model for UPDRS3, in training (N =
275, 87%) and test (N = 40, 13%) datasets, respectively. We
enrolled the participants in these two groups consecutively
(Supplementary Figure 1). Participants in the training dataset
lived a mean of 1.85 km (SD = 0.77) from the smelter, and
the participants in the test dataset lived a mean of 1.96Km
Abbreviations: AUC, Area under the ROC curve; Mn, Manganese; ROC, Receiver
operating characteristic; PD, Parkinson’s disease; PM2.5, Particulate matter ≤ 2.5;
UPDRS3, Unified Parkinson Disease Rating Scale motor subsection 3.
(SD = 0.74) from the smelter. The participants from Meyerton
comprised a subset of participants who were recruited as part of
a larger environmental Mn study (11). The recruitment approach
for this larger study was based upon the location of residence, and
was designed to obtain a true population-based sample within
three Meyerton-based settlements. Briefly, we pre-selected every
other residence (two communities) or all residences (one, smaller
community). We attempted to recruit all age-eligible adults in
each pre-selected residence to participate in the study, or, in the
two communities where only half of residences were selected, the
residence to the left if no one was home or eligible. Across the
three settlements in the Meyerton community, 462/666 (69.4%)
of homes that we visited had at least one eligible adult who agreed
to participate. Air monitoring in all three Meyerton settlements
confirmed relatively highmean concentrations of PM2.5-Mn (203
ng/m3 at a long-term fixed site in one settlement, and based upon
concurrent sampling approximately half that level in the other
two settlements) (11). This is ∼12–20 times higher than mean
PM2.5-Mn in other populated areas in South Africa (11, 12), and
∼4 times higher than the mean modeled PM2.5-Mn exposure
levels for anMn smelter community in the United States (13).We
therefore refer to all participants from this community as Mn-
exposed.
We externally validated our model in 90 additional
participants, also >40 years old, from a community in the
same province, Ethembalethu. Ethembalethu was smaller than
theMeyerton-based settlements, so we attempted to recruit every
age-eligible resident using the same door-to-door approach to
obtain a population-based sample. In this community, 79/108
(73.1%) of homes that we visited had at least one age-eligible
adult who agreed to participate. Ethembalethu is an industry-
free community, with no nearby Mn smelting or mining
operations, located ∼70 km from Meyerton. Air monitoring in
Ethembalethu demonstrated mean concentrations of PM2.5-Mn
∼20 times lower than at the fixed site in Meyerton (10 ng/m3)
(11). This is ∼40% lower than mean PM2.5-Mn levels measured
in the air in a city on the southeastern coast of South Africa
with some industry but no Mn smelting or mining activities
(12). We therefore refer to all participants from Ethembalethu
as non-exposed.
For inclusion in the present work, we required participants
in both communities to meet the following criteria: (1) be
non-ambidextrous (self-report as right-handed or left-handed),
(2) complete at least one trial for the dominant and non-
dominant hand for each of five motor tasks under the direction
of a trained test administrator, (3) have been examined by
a movement disorder specialist using the UPDRS3 and had
complete UPDRS3 data. Exclusion criteria were: (1) current use
of neuroleptic medications, and (2) neurologic co-morbidities
that might compromise the accuracy of the UPDRS3, such as
stroke or spasticity.
In order to include individuals with other conditions that
would cause incomplete UPDRS3 data, such as injured/missing
limbs or inability to undergo the pull test to assess balance, we
used imputation of the respective subscore(s) to obtain complete
UPDRS3 data when possible. We included individuals regardless
of UPDRS3 score, presence of PD, or occupational Mn exposure,
Frontiers in Neurology | www.frontiersin.org 2 May 2021 | Volume 12 | Article 653066
Dlamini et al. Motor Task-Based Parkinsonism Screening Tool
in order to ensure that our original population-based samples
remained representative of the respective settlements. The above
exclusions, need for imputation, presence of PD, and past or
current occupational Mn exposure were all uncommon (all
<2.5%) in the larger study (11).
All recruitment, testing, and examination occurred in 2016–
2020 (11).
Grooved Pegboard and Kinematic Testing
Participants completed five motor tasks—the grooved pegboard
task and four accelerometry-based kinematic-UPDRS3 tasks—in
their homes, at the time of enrollment into the original study.
These kinematic-UPDRS3 tasks were designed to characterize
finger tapping, hand rotation, action tremor, and postural tremor.
All participants had grooved pegboard and kinematic testing
conducted by one of three non-clinician test administrators. We
trained all three test administrators previously using a video-
based training module, followed by supervised administration
of the tests to non-research participants. In addition, we
made frequent data quality checks throughout the study.
For the grooved pegboard task, we used a standard grooved
pegboard device (Lafayette Instrument Company, Lafayette,
Indiana) and followed published testing procedures (14). For
the four kinematic tests, test administrators placed a wireless
motion sensor (KinesiaTM, Great Lakes NeuroTechnologies,
Independence, Ohio) (15–19) on the top of the participant’s index
finger. The Kinesia Motion Sensory device comprises a triaxial
accelerometer and triaxial gyroscope, allowing measurement of
acceleration (linear) and velocity (angular), respectively, along
all three axes (x, y, and z) at 64 Hertz. We recorded the
digitized signals on a computer tablet, using motion capture
software (Great Lakes NeuroTechnologies, Independence, Ohio),
following at least one non-recorded practice trial. Participants
then completed three 12-second trials while seated for each hand
for each task: (1) postural tremor—participant was instructed
to raise both arms, straight out in front of his/her body
and stay as still as possible; (2) action tremor—participant
alternated touching his/her index finger to his/her nose and to
the administrator’s finger held an arm’s length away from the
participant; (3) finger tapping—participant tapped his/her index
finger and thumb together while keeping the other fingers stable
and the elbow extended; (4) hand rotation—participant rotated
his/her hand at the wrist, positioning the arm so that the elbow
was flexed and the hand open. Participants were instructed to
perform finger tapping and hand rotation tasks with as large
an amplitude and as fast, as possible. Participants completed
the trials for the right hand first, followed by the left hand, for
each of these four tasks. A previous study in PD patients that
used a similar Kinesia Motion Sensory device found that in the
more parkinsonian hand the test-retest reliability across three 15-
s trials, as measured by the intraclass correlation coefficient, was
0.71 for postural tremor and 0.94 for finger tapping speed (18).
We then developed, validated, and applied comprehensive
computer code to process these large datasets
(Supplementary Material 1). Specifically, we first checked
and standardized data from each trial. For example, we removed
kinematic data for trials that appeared to be incomplete
(<12 s) or for sensor failures. We then calculated six
summary measures across the three trials (mean velocity,
mean peak velocity, coefficient of variation, decrement in
peak velocity, cycles/second, and decrement in cycles/second;
Supplementary Table 1). We also calculated three summary
measures for each hand from grooved pegboard testing (time
to place all 25 pegs, number of pegs placed, number of pegs
dropped). We calculated all of the kinematic and grooved
pegboard measures for each hand (dominant, non-dominant),
using a mean of all ≤3 trials and by taking only the first
trial. As an additional variation for mean velocity for the
finger tapping and hand rotation tasks, we isolated both the
upward/downward motions and the clockwise/counterclockwise
motions, respectively.
Assessment of UPDRS3 Score and
Subscores
Onemovement disorder specialist (BR) examined all participants
using the UPDRS3 (20), blinded to performance on the
grooved pegboard and kinematic motor tasks. The examination
occurred in one central non-clinical location in each of the two
communities, while study staff conducted the testing in-home on
an earlier date (a median of 37 and 3 days earlier, respectively, for
Meyerton and Ethembalethu) without the examiner present, and
individual testing results were not available to the examiner. In
addition to UPDRS3 total score, we focused on selected UPDRS3
subscores (upper limb bradykinesia and tremor) to facilitate
validation and selection of grooved pegboard and kinematic
summary measures for development of the prediction of the total
UPDRS3 score (Supplementary Material 2).
Determination of Handedness and
Demographic Variables
We used self-reported handedness to classify UPDRS3 subscores
and the five motor tasks as dominant or non-dominant.
Participants also provided socio-demographic information,
including age, sex, ethnicity, and home language.
Statistical Analysis
We performed all data processing and statistical analyses using
Stata version MP 14.2 (StataCorp, College Station, Texas) (21).
To help prioritize which summary measures to include in
the predictive model, we estimated Spearman’s ρ correlation
coefficients between each of the kinematic and grooved pegboard
test summary measures and the respective UPDRS3 subscores
(our gold standard) (Supplementary Material 2). Specifically,
we sought to identify summary measures with the Spearman’s
ρ correlation coefficients of the greatest magnitude (relative to
each other, or at least weakly or significantly correlated, i.e.,
ρ > 0.20 and/or with p < 0.05) and, more importantly, in
the expected direction (positive or negative). Greater UPDRS3
scores and subscores indicate greater parkinsonism, which we
anticipated would be associated with longer grooved pegboard
times, fewer pegs placed, and more pegs dropped. With regard
to the kinematic tests, we also anticipated that greater UPDRS3
scores would be associated with lower velocities (or fewer cycles
per second) and greater decrement (and hence greater variability
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as assessed by the coefficient of variation) on the finger tapping
and hand rotation tasks. We investigated whether correlations
differed according to hand dominance and whether motor task
data from only one hand might be sufficient to predict UPDRS3.
We also examined the association between summary measures
derived from only the first of the three trials to determine if a
single trial would be sufficient for UPDRS3 prediction.
Model Development
We used linear regression with the total neurologist rated
UPDRS3 as the outcome variable, to predict UPDRS3 in our
training dataset (N = 275). Age and motor task summary
measures selected above were our primary a priori predictors
of interest, and we initially retained all as continuous measures
(8, 22). We then used locally weighted scatterplot-smoothing
(LOWESS) graphs to determine, for each of these predictors,
whether linear modeling or other approaches were most
appropriate. The LOWESS graphs suggested a quadratic term
for hand rotation and finger tapping mean velocities, which
we verified and confirmed to be true for only hand rotation
(In a simple linear regression between UPDRS3, hand rotation
mean velocity, and its quadratic term, the quadratic term was
statistically significant; therefore, we included this term in our
model. In contrast, the square term for finger tapping was
not statistically significant when including finger tapping mean
velocity). To assess multicollinearity, we used the variance
inflation factor (VIF) and conservatively verified that the VIF was
<2 for all predictors in our final model. The exception was the
hand rotation linear term and its quadratic term because these
are inherently correlated, so both were included to better capture
the true association between that predictor variable andUPDRS3.
Secondarily, we repeated this model development process but did
not allow age to be included as a predictor, given that age in the
Mn-exposed community could be a surrogate for duration of Mn
exposure, and therefore the coefficient for age might not translate
well to settings without this potential cause of parkinsonism.
Model Validation
We formally validated model performance in our test dataset
(N = 40) and in the independent, external dataset (N = 90),
using the receiver operating characteristic (ROC) curve (21, 23).
We estimated the area under the ROC curve (AUC) using a
dichotomized UPDRS3 variable (UPDRS3 ≥ 10 and UPDRS3 ≥
15, when possible) as our gold standard. We used a UPDRS3
score of 15 as a cut point because most idiopathic PD patients
become symptomatic and present for medical attention with
UPDRS3 scores ≥15 (24–26), i.e., that this threshold would
reflect functionally impairing motor dysfunction. We also used
a UPDRS3 score of 10 as a cut point because our primary
focus was to develop a screening tool, i.e., one would likely
use a more conservative (lower) UPDRS3 than 15. We also
calculated sensitivity and specificity for these same gold standard
variables at selected predicted UPDRS3 cut points. In order to
obtain an overall measure of whether the predicted UPDRS3
might be suitable for use as a continuous outcome measure in
epidemiologic studies, we calculated Spearman’s ρ correlation
coefficient to measure agreement between neurologist-assessed
UPDRS3 and themodel-derivedUPDRS3.We calculated the 95%
confidence interval (CI) for this ρ and for the AUCs. Obtaining
an estimate for the lower CI is more informative than a p-value.
A CI for ρ that excludes zero indicates significance at a two-sided
α = 0.05, but for this particular comparison we viewed a lower
CI > 0.20 to indicate clearly that the observed correlation was
at least weakly positive. An AUC of 0.5 indicates discrimination
ability no better than chance, an AUC of 0.7 is fair, an AUC of 0.8
is good, an AUC of 0.9 is excellent, and an AUC of 1.0 indicates
perfect discrimination (27). Therefore, we viewed a lower CI >
0.70 to indicate clearly that the observed AUC was at least fair.
RESULTS
Characteristics of Participants
Most (98.5%) of participants were of black/African ethnicity, with
a median age of 51 (Table 1). The mean UPDRS3 score was
7.9 (SD = 6.3, range 0.0–38.5), but differed markedly between
the two communities. Upper limb bradykinesia contributed
substantially to UPDRS3 as 16.8% of participants had >6 points
in total across the six upper limb bradykinesia subscores, i.e., a
subscore of >1 on at least one of these six scores (not shown).
In contrast, action/postural tremor was relatively uncommon.
Only 20 (4.9%) of the participants had an action/postural
tremor subscore of 2, and only three participants had prominent
action/postural tremor or only rest tremor (subscore >2).
Three participants who had complete kinematic and grooved
pegboard data, all from Meyerton, had PD according to this
neurological examination.
Performance of Summary Measures
Several summary measures for upper limb bradykinesia
correlated with the respective UPDRS3 subscores
(Supplementary Table 2), with grooved pegboard time and
hand rotation and finger tapping mean velocities demonstrating
the greatest agreement. Of these three measures, the mean
velocity for hand rotation demonstrated the best agreement
(ρ =−0.43 and ρ = −0.42 for the dominant and non-dominant
hand, respectively), with the corresponding UPDRS3 subscore,
i.e., rapid alternating movements. Agreement for these kinematic
summary measures was not improved by isolating the direction
of the movement, i.e., upward vs. downward motions within
finger tapping or clockwise vs. counterclockwise motions within
rapid alternating movements. The other kinematic summary
measures (cycles/second, decrement in peak velocity, and
decrement in cycles/second) did not perform as well as mean
and peak velocities as a measure of upper limb bradykinesia. Of
these, the greatest agreement was for coefficient of variation and
“decrement” in the non-dominant hand for the hand rotation
task (Supplementary Table 2).
The absolute value of the correlation coefficients between
the action/postural tremor summary measures and UPDRS3
subscore were all well below 0.20 (action tremor task:
ρ =−0.06 to 0.08; postural tremor task: ρ = −0.11 to 0.06;
Supplementary Table 3).
When comparing a given measure to the respective UPDRS3
subscore, dominant and non-dominant hands yielded similar
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Characteristic n (%) n (%)
Sex
Male 160 (39.5) 122 (44.4) 10 (25.0) 28 (31.1)
Female 245 (60.5) 153 (55.6) 30 (75.0) 62 (68.9)
Black/Africana 398 (98.5) 271 (98.6) 40 (100.0) 87 (97.8)
Languageb
Sesotho 194 (48.1) 155 (56.8) 26 (65.0) 13 (14.4)
IsiXhosa 57 (14.1) 47 (17.2) 4 (10.0) 6 (6.7)
IsiZulu 60 (14.9) 40 (14.7) 4 (10.0) 16 (17.8)
Otherc 92 (22.8) 31 (11.4) 6 (15.0) 55 (61.1)
Educationd
None/non-formal schooling 58 (14.3) 38 (13.8) 11 (27.5) 9 (10.0)
Primary 150 (37.0) 94 (34.2) 18 (45.0) 38 (42.2)
Secondary 130 (32.1) 96 (34.9) 6 (15.0) 28 (31.1)
Matric or higher 67 (16.5) 47 (17.1) 5 (12.5) 15 (16.7)
Ever Mn occupational exposure 10 (2.5) 10 (3.6) 0 (0.0) 0 (0.0)
Current Mn occupational exposure 2 (0.5) 2 (0.7) 0 (0.0) 0 (0.0)
UPDRS3 ≥ 10 146 (36.1) 119 (43.3) 20 (50.0) 7 (7.8)
UPDRS3 ≥ 15 60 (14.8) 51 (18.6) 6 (15.0) 3 (3.3)
Characteristic Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Age, years 52.4 (8.7) 51.3 (8.2) 53.2 (9.8) 55.6 (8.6)
Minimum 41 41 41 41
25th percentile 45 45 44.5 51
Median 51 50 51.5 55
75th percentile 57 56 60 59
Maximum 84 81 79 84
Distance from Mn smelter, km –e 1.85 (0.77) 1.96 (0.74) –e
Minimum –e 0.83 0.97 –e
25th percentile –e 1.22 1.21 –e
Median –e 1.54 2.10 –e
75th percentile –e 2.80 2.51 –e
Maximum –e 3.15 3.15 –e
UPDRS3 7.9 (6.3) 9.1 (6.4) 9.1 (6.1) 3.9 (4.3)
Minimum 0.0 0.0 0.0 0.0
25th percentile 2.5 4.0 4.0 1.0
Median 7.0 8.0 9.5 2.0
75th percentile 12.0 13.0 13.0 5.5
Maximum 38.5 38.5 29.5 21.5
Non-dominant hand grooved pegboard time, secondsf 119.7 (48.5) 116.2 (47.6) 139.5 (56.2) 121.7 (45.5)
Minimum 51.4 51.4 64.9 60.0
25th percentile 85.2 85.0 93.8 85.1
Median 106.0 103.8 121.5 113.5
75th percentile 135.7 129.9 182.4 151.7
Maximum 300.0 300.0 300.0 241.1
(Continued)
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Characteristic Mean (SD) Mean (SD)
Non-dominant hand rotation, mean velocityg 597.1 (164.8) 614.2 (177.0) 574.2 (174.5) 583.5 (163.7)
Minimum 233.9 151.7 280.4 236.9
25th percentile 480.0 487.6 452.1 449.7
Median 594.0 610.9 516.1 587.6
75th percentile 699.8 729.7 696.8 686.9
Maximum 1,257.7 1,257.7 1,013.3 975.9
Non-dominant finger tapping, mean velocity 352.5 (118.1) 352.0 (115.6) 395.8 (162.1) 408.2 (124.5)
Minimum 87.8 95.5 138.7 168.5
25th percentile 269.0 268.8 282.3 316.3
Median 343.5 347.3 395.5 413.2
75th percentile 426.3 432.0 470.2 507.5
Maximum 727.0 699.0 727.0 679.1
SD, standard deviation; UPDRS3, Unified Parkinson’s Disease Rating Scale motor subsection 3; Mn, manganese; km, kilometer. aTotal and external validation dataset percent excludes
1 participant with missing data for race. Other 6 participants were white or of mixed race. bTotal and training dataset percent excludes 2 participants with missing data on language.
cSetswana, Sepedi, Xitsonga, Afrikaans, SiSwati, and Tshivenda. dPrimary is grades 1–7, secondary is grades 8–11, and matric is grade 12. eOnly shown for participants from the Mn
smelter community of Meyerton; the non-exposed community of Ethembalethu is >70 km from Meyerton. fTotal and external validation dataset excludes 2 participants with missing
data for this motor task. gAll available kinematic trials, except for the training dataset, in which only the first kinematic trial was used for development of the UPDRS3 predictive model,
in order to minimize the time required to conduct screening.
Spearman’s ρ correlation coefficients (Supplementary Table 2).
However, testing from the non-dominant hand performed
slightly better for the “decrement” summary measures. We found
similar correlations between UPDRS3 and kinematic testing
when we used only the first trial, rather than the mean of all
available trials (Supplementary Table 4).
UPDRS3 Predictive Model
The final model included the following predictors for one trial
from the non-dominant hand: hand rotation kinematic mean
velocity linear term and quadratic term (squared term); finger
tapping kinematic mean velocity; grooved pegboard time; and
age, each as linear terms (Table 2, Figure 1). Finger tapping
and hand rotation mean velocities were inversely associated
with UPDRS3, whereas age and grooved pegboard time were
positively associated with UPDRS3. Administration of the tests
selected for this screening tool for this predictive model took
<10min (Figure 1).
Model Performance
In our test dataset, performance of the predictive model as
measured by the AUC was 0.81 (95% CI 0.68, 0.94) for
identifying participants with neurologist-assessed UPDRS3 ≥
10 (Figure 2). The model performed even better for identifying
participants with UPDRS3 ≥ 15 (AUC = 0.91, 95% CI
0.81, 1.00). When identifying participants with UPDRS3 ≥
10, sensitivity and specificity were equal at 70.0%, when
applying a cut point of 8 for the predicted UPDRS3 score
(Supplementary Table 5). Sensitivity (83.3%) and specificity
(79.4%) were relatively similar for identifying participants
with UPDRS3 ≥ 15 when using 11 as the cut point for
the predicted UPDRS3 score. With 9 as the cut point, the
model identified all participants with a UPDRS3 ≥ 15 (100%
sensitivity) while allowing for a specificity of 67.7%. When
retaining the predicted UPDRS3 score as a continuous measure,
agreement as measured by Spearman’s ρ between the neurologist-
assessed UPDRS3 and predicted UPDRS3 was 0.67 (95% CI
0.48, 0.87).
When we applied our predictive model to the external
validation dataset, the AUC was 0.85 (95% CI 0.73,
0.97) when identifying participants with UPDRS3 ≥ 10
(Supplementary Figure 2). Too few participants in this
sample had a UPDRS3 ≥ 15 to construct a smooth ROC
curve. When attempting to identify participants who had
a UPDRS3 ≥ 10, a cut point of predicted UPDRS3 of 4
resulted in sensitivity of 83.3% and specificity of 68.3%
(Supplementary Table 6). Agreement between the neurologist-
assessed and predicted UPDRS3 as continuous variables
was 0.58 (95% CI 0.46, 0.74).
When we explored the effect of using only the motor tasks as
predictors, i.e., removing age from the model, AUCs were only
modestly attenuated. In our test dataset the AUC was 0.76 (95%
CI 0.60, 0.91) for UPDRS3 ≥ 10 and 0.86 (95% CI 0.72, 1.00) for
UPDRS3 ≥ 15. In the external validation dataset the AUC was
0.82 (95% CI 0.67, 0.98).
In a post-hoc exploratory analysis in which we considered how
well the predictive model might identify the three individuals
with PD in Meyerton (training and test datasets combined), the
predicted UPDRS3 scores were 16.3, 17.1, and 21.7, all above the
UPDRS3 ≥ 15 cut point.
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TABLE 2 | UPDRS3 predictive model in the training dataset (N = 275), South Africa, 2016–2020.
Unadjusted Mutually adjusteda (final predictive model)
Characteristic Linear regression βb 95% CI p-value Linear regression βb 95% CI p-value
Motor tasks (non-dominant hand)
Hand rotation mean velocityc −0.0395 −0.06, −0.02 <0.001 −0.0251 −0.04, −0.01 0.01
Hand rotation mean velocity squaredc 0.00002 0.00001, 0.00004 0.01 0.00001 −0.000001, 0.00003 0.08
Finger tapping mean velocityc −0.0162 −0.02, −0.01 <0.001 −0.0081 −0.01, −0.002 0.01
Grooved pegboard time, seconds 0.0547 0.04, 0.07 <0.001 0.0374 0.02, 0.05 <0.001
Age, years 0.2177 0.13, 0.31 <0.001 0.0685 −0.02, 0.16 0.14
Constant –d –d –d 13.8134 5.64, 21.99 0.001
CI, confidence interval; UPDRS3, Unified Parkinson’s Disease Rating Scale motor subsection 3. aMutually adjusted indicates that all estimates are adjusted for all listed variables. When
excluding age (non-significant) the constant was 17.0251, the coefficients were as follows: −0.0245 for hand rotation, 0.00001 for hand rotation squared, −0.0093 for finger tapping,
and 0.0421 for grooved pegboard. bDifference in UPDRS3 score per unit change in the motor tasks and age. cFirst kinematic trial. dDiffers for each model.
FIGURE 1 | Parkinsonism Screening Tool. A simple motor task screening tool based on the predictive model, which is shown in detail in Table 2. UPDRS3, Unified
Parkinson’s Disease Rating Scale motor subsection 3.
DISCUSSION
In this large study in South Africa we predicted the UPDRS3
score with a limited battery of kinematic and grooved pegboard
tests administered by trained non-clinician community
members in <10min per participant. AUCs in two validation
datasets demonstrated that performance of this predictive
model for identifying individuals with UPDRS3 scores ≥10
or ≥15 was good to excellent. In addition, we confirmed
that there was at least a moderate correlation between the
predicted UPDRS3 scores and neurologist-assessed UPDRS3.
Notably, this UPDRS3 predictive model worked equally
well in communities with and without environmental Mn
exposure, i.e., in population-based samples with either
relatively high or relatively low UPDRS3 scores. Taken
together, our findings indicate that this UPDRS3 predictive
model likely can be applied to facilitate screening programs or
research studies in a wide variety of settings, including under-
resourced environments with limited access to PD specialists or
other neurologists.
In all potential applications of this UPDRS3 predictive model,
the first step after administering the three-test battery is to
calculate the mean velocities from the two kinematic tests.
Of the many kinematic summary measures we assessed, the
mean velocities are the easiest to calculate, further ensuring the
potential usefulness of our model in many situations. Calculation
of these summary measures only requires the isolation of the
kinematic data from the relevant axis, i.e., x-axis for finger
tapping and y-axis for hand rotations, before taking the mean
across all sampled time points with the respective movement. In
the second step, these two means from kinematic testing, along
with the grooved pegboard time and age, are simply inserted into
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FIGURE 2 | Receiver operating characteristic curves for identifying individuals with UPDRS3 ≥ 10 and UPDRS3 ≥ 15 in a population-based sample with
environmental Mn exposure, South Africa, 2016–2020. The AUCs indicate that the UPDRS3 predictive model performed well. AUC, area under the receiver operating
characteristic curve; UPDRS3, Unified Parkinson’s Disease Rating Scale motor subsection 3; Mn, manganese.
the equation produced by our predictive model. The resulting
UPDRS3 score could be used in an epidemiologic study in which
it is not possible for a neurologist to examine any participants.
Alternatively, in a third step, one would dichotomize the
predicted UPDRS3 score according to a pre-selected cut point
to identify individuals with a particular UPDRS3, corresponding
to the desired sensitivity and specificity. One likely would
dichotomize the predicted UPDRS3 scores at the lowest possible
cut point so as to achieve the highest sensitivity that is feasible,
given that a specialist would need to examine all individuals with
predicted UPDRS3 scores above the selected cut point. As part of
a tiered screening protocol, maximizing sensitivity would either
facilitate clinical care to the largest percentage of people in a
community who might benefit from treatment, or alternatively
would minimize misclassification of research study participants
in terms of a dichotomous outcome of interest. As evidence of the
potential utility of this type of protocol, a similar tiered screening
approach was adopted in a previous occupational Mn exposure
setting in South Africa (28).
We acknowledge some limitations that could affect usefulness
of our predictive model. First, the kinematic methods may
not be easily incorporated in all settings. We trained our
fieldworkers extensively in the use of kinematic devices, and
we view this training as essential. Second, kinematic testing
generates large amounts of data, requiring expertise in data
handling. In addition, a substantial amount of computer storage
and computational power would be required to process these
data for many individuals at once, which might be a challenge in
under-resourced environments. Third, while we used a common
motion capture device, such devices have unique operational
principles, instrumentation, and type of data produced (29) so
data from other devices might not be ideal for use in our model.
Finally, while a UPDRS3 score from a predictive model might
not be as accurate as neurologist assessment, our tool is more
objective than the UPDRS3. As a result, our model can address
potential important challenges that might arise in epidemiologic
studies, such as examiner blinding.
The strengths of our study include the use of one movement
disorder specialist to obtain gold standard UPDRS3 ratings,
the relatively large sample size, and a unique study population
at risk for parkinsonism paired with a lower risk population,
each representative of their underlying communities. These
strengths positioned us well to develop and validate the resulting
UPDRS3 predictive model, which also has several strengths.
First, we were successful in minimizing the time required to
complete the included motor testing without materially affecting
performance of the UPDRS3 predictive model. Most notably,
we confirmed that it was sufficient to conduct only one trial
of the selected tests in one hand. Second, all predictors can
be assessed objectively, i.e., without subjective assessments that
might require clinical expertise. Although some prior predictive
models of UPDRS3 score or “parkinsonism” benefitted from
the use of objective motor assessment (either a different fine
motor task or gait assessment), some of these models required
test administrators to make clinical judgements (30, 31). Third,
no translation of questions or questionnaires is required beyond
obtaining age. Some prior predictive models required assessment
of selected medical conditions (30, 31), as might be done via
questioning, or even administration of full questionnaires (32).
Translation burden (33), and population literacy makes a purely
questionnaire-based screening protocol especially challenging to
administer in low-resourced countries. Avoiding the need for
translation is especially beneficial in the context of Africa and
other locales in which many languages are spoken.
Restriction of our model to age and a modest battery of
objective motor tasks to avoid the above potential challenges did
not come at the expense of performance. Previous occupational
or community-based cohorts in which investigators attempted
to identify people with parkinsonism achieved AUCs ranging
from 0.72 to 0.79 (30–32). The predictive model we present
achieved slightly better AUCs than in these studies. Both the
grooved pegboard test and the finger tapping task, such as
assessed in a similar manner as here, have been shown to
provide good discrimination between existing PD patients and
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comparable controls previously, with AUCs as high as 0.80–
0.87 (34, 35). While our study is unique in the use of these
particular tests in population-based non-patient populations to
estimate a UPDRS3 score, our results are consistent with these
prior studies, suggesting that these motor tests are useful in a
variety of study or clinical populations. Nonetheless, validation
of our exact predictive model before its application in additional
populations is recommended. However, we anticipate themodel’s
usefulness in additional populations, given the model worked
well to predict UPDRS3 in two communities with markedly
different mean air Mn levels and UPDRS3 scores. While we were
only able to explore the potential performance of the model
in identifying PD in one of these communities, those results
were very encouraging, as well. These findings demonstrate the
robust predictive ability of the model in multiple practice settings
and further underscore the usefulness of selected motor tasks in
screening for parkinsonism.
In summary, using selected accelerometry-based kinematic-
UPDRS3 tasks and the grooved pegboard, we developed
a UPDRS3 predictive model to identify individuals with
potential parkinsonism, which demonstrated good predictive
ability. The model performed exceptionally well considering
that we applied it in non-patient populations and relied
on non-clinicians to administer the tests. These findings
have important public health applications in screening for
or assessing parkinsonism in clinical or research settings
in regions of the world with limited clinical neurologic
expertise. The proposed screening tool provides an alternative
assessment in these low-resourced environments because of ease
of administration.
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